Good morning.
Futures pointing to a cautious open after hyperscaler CDS hit record wides yesterday — bond market sending a clear signal on AI capex ROI. SPX flat, NDX +0.2% as semis try to recover. BE +12% pre-market on that expert call: turbine OEMs refusing to expand capacity creates a multi-year window for Bloom, LCOE gap small enough to stick. INTC up 5% AH — 7th straight beat, capex raised from $18B to >$20B for 2026, foundry external revenue accelerating +68% q/q. AVGO +3% after Google’s LT purchase commitments leapt to $811B, de-risking the TPU relationship through 2031 with rising minimum volumes. Asia mixed: KOSPI supported by Korean presidential chief of staff signaling "very large-scale" US tech contracts (HBM read-through), but China tech under pressure on open weights regulation fears.
Three themes framing the tape today:
1. AI capex fatigue meets reality. Bond market is screaming — ORCL CDS disintegrating, utilities dragged. But the Convequity barometer says ROIC/WACC still at 3.05x. The tension between near-term financing risk and structural demand isn’t resolved, just priced differently in credit vs equity. 2. Bloom’s window just got longer. That Tegus call is the strongest single read we’ve seen on BE. Gas turbine OEMs are deliberately not expanding capacity — they fear double-booking and stranded factories. Bloom’s solid-state supply chain can ramp faster, 20 GW backlog vs 1.5 GW deployed. Q2 print on the 28th is the execution checkpoint. 3. Google/AVGO: the silo is locked. $811B in purchase commitments implies >$1T in capex over 5 years. AVGO’s custom silicon pipeline is de-risked through 2031. Cloud growth at 81% yy with 35.7% op margin validates the ROIC story — but FCF turning negative for the first time is the asterisk we’ll be watching. 4. Open weights lobbying gets real. Jensen’s first X post is a manifesto. NVIDIA, MSFT, META aligned against Anthropic/OpenAI. This is a defensive play to protect CUDA from merchant silicon — the battle lines are drawn and policy outcome matters for the merchant chip thesis.
We’ll hit up AVGO, BE, and INTC first, then get to semis and datacenter plays.
Verdict: The stock has already repriced the turnaround. Now you're waiting on one thing – a signed external foundry customer. The earnings beat was real, the capex raise is aggressive, and the multiple is TSMC-parity. Bulls say the flywheel is spinning. Bears say you're paying for a future that hasn't arrived yet.
112% revenue beat, $0.42 EPS vs $0.22 consensus. Margins back above 40% for the first time in two years. DC&AI up 59% YoY. Stock up 172% YTD, 343% over the past year. 18A yields ahead of schedule, 14A ramping in 2028. But capex is going >$20B this year, >$25B next year – and FCF turns negative again. The market is pricing in TSMC-parity on a forward P/S basis, but no external foundry customer has been announced.
13 analysts in the mix. PT range from $80 (Rosenblatt – Sell) to $200 (HSBC – Buy). The cluster: most Holds/Neutrals sit at $100-$125 (DA Davidson $100, Truist $108, Mizuho $109, Stifel $110, TD Cowen $115, Baird $125, Cantor $125). The bulls: BofA $160, KeyBanc $155, HSBC $200. The lone bear: Rosenblatt $80. Consensus is effectively a "wait for proof" camp – impressed with execution, but valuation strains imagination.
Bull case (BofA, HSBC, KeyBanc, Seaport): The data center CPU business is in a cyclical upswing driven by Agentic AI, and Intel is the primary beneficiary of US onshoring. 18A yields are ahead of plan, external customer discussions are "more tangible" (BofA). The capex hike is a proof point of real customer commitments (Seaport). HSBC’s 2027 DCAI revenue estimate is $36.7B, 29% above consensus. Gross margins have room to expand as 18A ramps – HSBC sees 45.3% in 2027 vs consensus 42.6%. The stock is still cheap relative to the long-term earnings power ($6 EPS by 2030 per Cantor, discounted back).
Bear case (Rosenblatt, Needham, Truist, Mizuho): The valuation is already pricing in a perfect turnaround. At ~36x EV/EBITDA, you're paying TSMC-parity for a company still losing server CPU share to AMD and missing the AI accelerator game. The capex surge means negative FCF through at least 2027 (Truist). No external foundry customer has signed – and management won't provide clarity near-term (Cantor). Client revenue is being pulled forward, and 2H26 client is below seasonal. The "easy" re-rating is done; the next leg requires fundamental proof that hasn't materialized.
Every analyst, bull and bear, points to the same thing: a front-end foundry customer announcement. The 18A yields are good, EMIB-T backlog is growing, Seaport says the capex raise implies real commitments. But no name yet. The stock went from $20 to $142 on narrative alone. Now it's $100. The next leg up requires a named external customer. Without it, the multiple can't expand further.
"The 2026 re-rating has already priced a meaningful portion of the early turnaround. The most important 14A catalyst, a signed external foundry customer, has not yet arrived." – Stifel
"We maintain our NEUTRAL rating and raise our price target to $100 from $77 on INTC following strong 2Q26 earnings. We view the aggressive Capex raise as a proof point that Intel is likely to see continued customer acquisition as the United States demands more domestic semiconductor manufacturing." – DA Davidson
"External manufacturing customer discussions have reached a more tangible stage, leading to a capital expenditure boost." – BofA
"The raised capex signals confidence in Intel's products and foundry business. Investors are awaiting a front-end announcement regarding the foundry operations." – TD Cowen
Intel's success or failure is a direct read on the US semiconductor onshoring thesis and the viability of a second foundry ecosystem. If Intel lands a hyperscaler front-end customer, it validates the whole CHIPS Act narrative and puts pressure on TSMC (TSM) and AMD – TSMC loses a US capacity argument, AMD loses a CPU share competitor that has a captive process advantage. If Intel fails to close, it reinforces the supremacy of the Taiwan cluster and benefits TSMC and its fabless customers (NVDA, AMD). Watch for any cryptic CEO comments at upcoming conferences.
Verdict: The Advancing AI event was a banger. Street is scrambling to mark to a much bigger TAM and a credible multi-year revenue pipeline. But the stock is already up 152% YTD, trading at ~179x earnings. The bull case is now fully priced for 2027 — the debate is whether 2028+ can keep the momentum going without execution stumbles.
Consensus PT range: $540 (RBC) to $1,250 (Baird). The cluster of 8 other raises sits in the $635–$730 range. Median ~$670. Consensus EPS for CY27 is ~$19, with some bulls like UBS already at $30 for CY28. That’s the battleground: how much of that revenue stretch is real vs. fantasy.
Bull: AMD is the only credible #2 in AI silicon, and the demand function is still steepening. Agentic AI is not priced in. With Helios as a full-stack rack solution, AMD can capture share in inference where NVDA’s advantage is narrower. The Anthropic deal alone gets you to $880B market cap — and they have 3 other anchor customers. Revenue can compound at 50%+ through 2028. At 36x CY27 EPS of $19, that’s cheap if EPS hits $30 by CY28.
"AMD signaled its 2027 and long-term revenues are likely higher than consensus, with OpenAI and Meta on track and more Anthropic revenue in 2027 than anticipated." — Melius
Bear: Valuation leaves zero room for error. At 179x trailing, the stock is pricing in perfection. Execution risk is real — rack-scale systems are new, supply chain is tight, and NVDA’s counter-attack (Rubin, Vera) isn’t going away. RBC is waiting for Helios volume evidence before turning constructive. William Blair says “valuation embeds increasingly high expectations with little room for error.” The $1,250 Baird target assumes 15% GPU market share by 2030 — that’s an enormous leap from today’s ~5%.
"We would wait for evidence of Helios volume ramps before adopting a more constructive stance." — RBC Capital
VERDICT: EPIC CLOUD BEAT, HORRIFIC CAPEX HIKE. Stock is getting smoked (down ~6-7% to $320) because the market is laser-focused on the negative FCF print and the $195-205B capex guide for 2026 (up $15B at the midpoint). That free cash flow miss — first negative FCF quarter in memory — is the headline. But peel the onion and the cloud number is a monster. 82% YoY growth vs 63% last quarter. That's the tension.
PTs are all over the map post-print, reflecting genuine confusion on how to weight the capex vs. the cloud/TAM expansion. Range is $350 (DA Davidson) to $515 (Citizens). Consensus is not coalescing. You've got a cluster at $385-425 (Bernstein, Barclays, Piper) and outlier bulls at $515 (Citizens) and a $400 neutral (Freedom Broker). The $350-$375 crowd is the "capex spiral kills FCF" camp. The $425+ crowd is "TPU-as-a-service rewrites the cloud margin story."
BULL: This is a revenue acceleration story mispriced as a capex problem. Cloud growth re-accelerated to 82% — that's not incremental, that's a step-function. TPU-as-a-service disclosed $811B in purchase commitments in the 10-Q (up $479B QoQ). Barclays is right: this moves Alphabet from a "buy and build" to an "asset-light toll taker" on AI infra. At 17x earnings with a PEG of 0.14, you're paying for a slow-growth utility, not a company growing revs 20%. If cloud margins hold (35.6% OM this quarter), EPS power is enormous.
"Alphabet is launching a new business model where it sells tensor processing units directly to customers as a merchant vendor... the asset-light approach to AI infrastructure may improve Alphabet’s capital efficiency." — Barclays (Ross Sandler)
BEAR: The capex guide is a poison pill. $195-205B in 2026 and management explicitly said capex grows significantly in 2027 from a HIGHER base. That's not a 2-year problem — that's a structural shift in the business model. The bull case for Google was always about FCF generation. That's gone. Bernstein nails it: "Alphabet’s multiple will likely compress as search comparisons become more difficult and cloud margins decline." The negative FCF quarter is a canary. If cloud margins peak here, you're left with a declining search franchise subsidizing a commodity compute business. Hard pass at 17x.
"Alphabet reported its first negative free cash flow quarter as capital expenditures increased... sell-side estimates will likely rise following in-line search results, a substantial beat in cloud revenue." — Bernstein (Mark Shmulik)
NEW (from the print):
This is the template for the AI capex debate playing out across all hyperscalers. Google just gave the bull case (82% cloud growth) and the bear case (negative FCF) in the same quarter. Read-throughs:
Stock at $146.38, near 52-week lows. After-hours up 2%. The narrative is simple: cloud backlog strong, margins soft, guidance tempered. Market is pricing in H2 deceleration risk — but the bulls see a buying opportunity at 0.71 PEG.
Five firms out post-Q2. Consensus is cautiously constructive — no downgrades, but PTs are a mess.
PT range: $177 (BMO) to $319 (Bernstein). TD Cowen at $205, KeyBanc at €200 (~$220). That's a $142 spread — tells you everything about the debate. No one is bearish enough to sell, but no one is raising targets aggressively either.
The collective thesis: Q2 cloud backlog beat (CCB +26% vs 24% expected), but op margin +1pp reduction to FY26 EBIT guidance spooked the tape. M&A costs and token expenses — transitory per TD Cowen, but the market doesn't like "adjusted for one-time items" in an environment where IBM and PEGA already missed.
"SAP delivered a good second quarter with better-than-expected Current Cloud Backlog growth, though margins came in below expectations." — Bernstein SocGen
"Transitory operating margin pressure... token costs expected to normalize in H2." — TD Cowen
Headline miss: EPS $1.82 vs $2.03 est, Revenue $11.28B vs $11.44B. Sounds rough. But nobody is focusing on the P&L miss. The market is looking past it because:
KeyBanc explicitly said Q2 was "better than expected given low anticipations" — pointing to a low bar cleared. They even contrasted with ServiceNow's results the prior day (implied: SAP held up better).
Bull case: Cloud backlog momentum is accelerating, not decelerating. 26% CCB growth in a macro environment that's getting worse by the week. ECC sunset in 2027 forces upgrades — that's a multi-year demand wedge. PEG of 0.71 is cheap for a mission-critical ERP vendor. Bernstein sums it up: "Positioning should result in stock outperformance." If H2 margins normalize (token costs drop off), the op income guide is conservative. Buy at the 52-week low.
Bear case: Guidance implies H2 cloud revenue deceleration — KeyBanc explicitly flags it. Oppenheimer warns large deal cycles are lengthening because enterprises are blowing budgets on AI in H1, squeezing software budgets in H2. Margin pressure isn't just transitory — it's structural from M&A integration. And the Middle East overhang is real: management's own guidance hinges on de-escalation. Stock down 8% in a week — the tape is voting.
"Concerns that cycles for large deals could lengthen in H2 2026 due to high AI spending in enterprise IT budgets during H1." — Oppenheimer
SAP is the canary in the coal mine for European enterprise software — and by extension, for US names trading at higher multiples. If a mission-critical system with 0.71 PEG and 25% cloud growth can get crushed on a margin cut, what happens to the high-growth SaaS names with no earnings?
The bull case rests on H2 normalization. If token costs and M&A drag fade, margins snap back and the stock re-rates. If they don't, this becomes a value trap at $146.
Watch for any H2 demand commentary from European enterprise peers (Siemens, Dassault). SAP's CCB strength is the best single data point for the sector — but the margin weakness is the warning sign.
Verdict: TXN printed a banger quarter but sold off after hours. That tells you everything about positioning. This isn't a fundamental disappointment — it's a stocks-have-already-run-70%-YTD problem. The bull case is intact (cycle broadening, data center doubling, GM expansion) but the setup was so demanding that even a clean beat+raise wasn't enough to push multiples higher. The after-hours -3% is a positioning flush, not a thesis breaker.
Four updates this week, all raising PTs (except Cantor which stayed at $340 but maintained Neutral). Range: $305 (Mizuho) to $360 (Benchmark), with Rosenblatt at $350 and Cantor at $340. Consensus PT is effectively $345-350.
Consensus EPS estimates: $9.63 for CY27, $11.26 for CY28 (Cantor's numbers, broadly in line).
The bulls (Benchmark, Rosenblatt) focus on cycle acceleration + manufacturing moat. The bears/neutrals (Mizuho, Cantor) acknowledge the beat but flag valuation — TXN trades at ~31x CY27 P/E and 49x trailing. That's rich for an analog play, even a great one.
Bull (Acree, Rosenblatt): This is a multi-year cycle. DC revenue doubled and isn't slowing — QoQ acceleration from 90% to 100% YoY growth. Industrial up 10% QoQ, auto up 8%. Price increases are sticking and more coming. TXN's 30-week lead times and available clean room capacity mean they can capture share while competitors stretch to 52+ weeks. GM back above 61% and heading to 63%+ by year-end. The after-hours dip is a buying opportunity — setup was just too tight.
Bear (Mizuho, Cantor passive): The stock is priced for perfection. 70% YTD, 72% including today? You're paying 31x CY27 earnings for an analog semi that historically trades at 20-25x. CapEx is tracking ahead for 2026/2027, which depresses FCF. The after-hours selloff despite a beat suggests the market was already long and there's no marginal buyer left. Growth is recovering but it's a cyclical recovery — not structural AI growth. Multiple compression risk is real.
"Investors approached the report with a demanding setup, where strong numbers were required but a strong report alone did not guarantee additional multiple expansion." — Cody Acree, Benchmark
"Demand trends showed broadening strength, growing backlog and slight lead time extensions." — Cantor Fitzgerald
"Texas Instruments' years of expanding its manufacturing footprint positions the company to meet fresh demand while maintaining lead times around 30 weeks." — Rosenblatt
This print is bullish for the entire analog/comms/industrial semi complex — STM, NXPI, MCHP, ON Semi all get read-through. If TXN is seeing broad-based demand recovery (not just DC), that's a positive signal for the analog cycle turning. But the valuation caution applies to the group too — STM trades 20x, NXPI 18x, ON 15x. TXN at 31x forward is the premium name.
The bigger thematic: analog is catching up to AI in the narrative. DC is now a meaningful growth driver for TXN (12% rev), and it's growing faster than the AI accelerators. That's a structural change — analog used to be just auto/industrial cycles. Now it's also data center power management, signal chain, etc. If you believe DC capex stays elevated, analog has more runway than the market prices.
Bottom line: TXN is a great company in a strong cycle. The stock's reaction says more about positioning than fundamentals. Bulls use the dip to add. Bears wait for 25x. Both sides have data.
VERDICT: Strong quarter, messy optics. Record leasing, a beat-and-raise, and 18.5% revenue growth are real. But the 12M-share Blackstone dilution washes most of 2026 accretion, and the stock is down ~28% from its PT range. The debate is about timing, not the secular thesis.
CONSOLIDATED STREET VIEW: $222 – $250. Four analysts, three constructive, one neutral. PTs: Bernstein $226 (Outperform), TD Cowen $222 (upgraded to Buy), Citizens $250 (Market Outperform), KeyBanc Sector Weight (no PT, waiting for entry). Consensus is high-conviction bull on demand, cautious on near-term math.
WHAT’S NEW/INCREMENTAL:
BULL: Demand is real and accelerating. Revenue growth 18.5%, PEG ratio 0.2. Pricing power intact – Citizens says “industry pricing power remains strong and should continue.” DLR is the hyperscale partner of choice (global footprint, track record). Beat-and-raise quarter, record leasing in the 0-1MW sweet spot, 9GW pipeline. Double-digit FFO growth for “multiple years.” TD Cowen’s upgrade to Buy says: “potential for additional large signings… growth likely to accelerate in 2028.” The promote, though non-recurring, proves the asset monetization strategy works.
BEAR: Dilution is real. 12M shares wash accretion. The $0.50 promote is a one-off – don’t model it forward. KeyBanc stays Sector Weight, “awaiting a better entry point” on macro capex concerns. At ~$179, the stock trades well below every PT – market is pricing in execution risk or a cap-ex slowdown. Bernstein likes the story but admits “growth isn’t free.” The 2.72% yield is thin for a REIT with this much development spend. If hyperscale demand softens or interest rates stay sticky, the leverage story flips.
“Still like the story, but growth isn’t free; DLR delivered very strong quarter operationally… But the sneaky math is around the 12M shares issued on July 1 as part of the Blackstone buyout that effectively wash most of the 2026 accretion.” – Bernstein
“Record demand strength… potential for additional large signings in late 2026 and early 2027… continued data center price increases and changing designs to drive higher renewal spreads.” – TD Cowen (upgrade to Buy)
Verdict: Purgatory post-Shashua. Q2 beat the bogey but nobody cares. CEO is stepping down, the narrative is shifting from "computer vision leader" to "robotaxi fleet operator" and the market is punting the stock to single digits until someone shows them a map.
MBLY printed $0.19 vs $0.06 consensus on $508M revenue (consensus $482M). FY26 guide of ~$2.0B is a hair above the $1.98B bogey. EyeQ units guided to ~39M, up from a prior 38M. That's a solid operational quarter — beat and raise on units. BUT the stock is trading at $7.47, down 52% YoY. Why? Because the story changed.
Co-founder and CEO Amnon Shashua is stepping down. This ends a 12-year leadership run (UBS has covered him that entire time). He stays on the board, but the market hates leadership transitions in the middle of a business model pivot. MBLY is shifting from selling ADAS chips to owning and operating its own robotaxi service — that's a dramatically different capital intensity and risk profile.
Analysts collectively cutting PTs to $8-12 range (from prior $9-17 cluster) tells you the uncertainty premium is expanding:
"The firm will remain on the sidelines, believing the stock could be range bound until larger proof points and new leadership emerge. Mobileye is entering a phase focused on physical AI applications including robotaxis and humanoids, as well as operations and execution, rather than computer vision and software AI." — UBS (Neutral, PT $9 → $8)
Bear case (winning): China competition is a real headwind. Canaccord explicitly flags "increased competition from Chinese players" as a growth limiter. Beyond VW, traction is thin — Western OEMs are "sitting on the sidelines" navigating their own EV/AV identity crisis. ASP headwind from China mix. New CEO = strategy reset risk. Stock could drift lower until someone credible takes the wheel.
Bull case: The Q2 beat was clean — revenue above, EPS crushed, units guided up. Canaccord maintains Buy at $12 (highest PT on the street) pointing to robotaxi deployments with VW/Porsche/Audi in 2027 as catalysts. Mentee V4 model targeting 500 B2C units in 2028. Tesla FSD take-rates could be a macro tailwind for ADAS adoption broadly. If the new CEO has a credible plan, this is a $12 stock.
1. New CEO name. Who takes over tells you everything about strategy direction — operator vs technologist. 2. VW robotaxi milestones. Hamburg testing with Porsche in 2027. Trial production early 2027, commercial H2 2027. Those are the proof points. 3. China mix trajectory. ASP compression from China export growth is a near-term margin headwind that needs to stabilize. 4. Tax credit benefit. New Israeli R&D tax credit is earnings/cash accretive — gives MBLY financial flexibility during the transition (UBS flagged this).
Stock is pricing in maximum uncertainty. If you think the leadership transition is smooth and the VW robotaxi narrative holds, the r/r skews favorable off these levels. If you think Chinese competition eats MBLY's lunch before they get the fleet operational, $7 is not the bottom.
Call: Show-me story. Wait for the CEO announcement before getting constructive.
THE AI NARRATIVE IS INTACT BUT THE STOCK IS HATED. ServiceNow printed a beat-and-raise quarter that every bull wanted — $0.90 EPS vs $0.86 consensus, $3.99B revenue vs $3.93B, 23% constant currency growth (acceleration from 19% last quarter). Net new ACV beat by 50bps, driven by AI and cyber/risk. Yet the stock trades at $97.75, down 50% from a year ago. The disconnect is real and the debate is about whether the market is correctly pricing in a deceleration or incorrectly discounting a compounder.
Q2 FISCAL 2026: Revenue $3.99B (+23% cc), EPS $0.90. Subscription revenue guided higher for the full year. AI ACV continues to exceed management's internal plan and is on track to blow past the $1.5B FY2026 target. D.A. DAVIDSON REITERATES BUY, $170 PT. Cantor Fitzgerald keeps Overweight, $141, but flags a structural tension.
Beat across the board, but Cantor points out the fine print: the 175bps constant currency organic subscription revenue beat included 125bps PULLED FORWARD FROM Q3 — management says it's timing, not price or packaging. That matters for thinking about Q3 setup. Subscription gross margin ticked down 50bps to 81%, specifically attributed to increased AI usage (inference costs, not a structural problem, but a real headwind until they optimize).
Federal was better than expected — Armis and cyber products drove that. M&A in risk/security (Armis) ahead of plan. Flat headcount commitment from CY25 year-end through end of this year. Operating margins reiterated.
"The 125bps pull-forward is timing-related and not related to price or packaging changes... subscription gross margin declined 50bps tied to increased AI usage." — Cantor Fitzgerald
BULL: Secular AI platform consolidation is real. Enterprises are funneling AI-enabling spend onto NOW's platform. The $1.5B AI ACV target for 2026 is looking conservative. Guidance remains lowballed — management habitually sandbags. At $97.75, you're getting a 22% grower with 76.6% gross margins for ~23x forward earnings? That's the buy-the-hate setup. D.A. Davidson: "ServiceNow as a long-term share gainer."
BEAR: The market sees the margin compression from AI costs (81% sub gross margin, down 50bps) and the Q3 pull-forward creates a tough sequential compare. Stock dropped 50% for a reason — multiple compression in a "show me" environment where AI monetization is real but cost to serve is inflating faster than expected. The 125bps pull-forward is a caveat, not a nothingburger. And at $100B market cap, it's not exactly a small cap discovery.
Best-in-class execution in a hostile tape. The AI ACV trajectory is the real prize — if that accelerates past $1.5B, the bears lose their primary argument. But near-term, the margin story and Q3 pull-forward give cover for the stock to stay range-bound. PMs who own this are playing for the multi-year compound; downside is limited at these levels unless the AI narrative breaks. I'm watching Q3 subscription revenue trajectory vs. the pull-forward — if Q3 prints cleanly above guide, that's the catalyst.
THIS STOCK IS BOTH A BELIEVER AND A SANITY CHECK. MXL crushed Q2 and guided Q3 well above Street — $215M midpoint vs Stifel's $175M estimate — but the stock sold off after-hours anyway. That's the tension. The 429% YTD gain means every incremental dollar of upside is already discounted. Both Needham and Stifel raised PTs on the optical DSP ramp, but they're playing different games on multiple.
Beat-and-raise quarter. Q2 rev of $168.8M (55% YoY, 23% QoQ) cleared estimates by ~$4M. Non-GAAP EPS of $0.35 beat by $0.02. Not a blowout, but the real story is Q3 guide: $215M at the midpoint. That's 27% sequential growth in a seasonally flat period. All optical DSP.
The Keystone PAM4 is the engine. MXL raised FY26 DSP revenue guidance to $210-230M from $150-170M — that's a $60M step-up at the midpoint. Demand is coming from 800G deployments at multiple major customers in both US and Asia. Gross margin guided to 60% in Q3, which Needham had not expected until Q1 2027. That's two quarters ahead of schedule.
"Management expects 800G shipments to continue growing in 2027 as its 1.6T Rushmore DSP begins to ramp." — Needham
Both houses raised. Needham goes to $100 (30x CY28 non-GAAP EPS of $3.35). Stifel goes to $120 (47x CY27 P/E). That multiple divergence tells you everything. Needham is anchoring to a 2-year forward view; Stifel is pricing the momentum today.
Needham's $100 target: 30x on $3.35 CY28 EPS. That's a reasonable growth multiple if the ramp sustains — you're getting the Keystone cycle plus Rushmore sampling for late 2027 contribution. But $3.35 in two years requires optical revenue to keep compounding at 40%+ from here.
Stifel's $120 target: 47x on CY27 EPS. For a semi company that was sub-$3B market cap last year. That's expensive even by semis standards, but Stifel is leaning into the optical interconnects thesis — this is not your father's broadband modem business.
The optical DSP narrative is real. Keystone is shipping in volume. Rushmore is sampling. Margins are improving. The stock is priced for perfection. If you're long, you're betting the 800G->1.6T transition is multi-year and MXL takes share. If you're adding today, you better believe in 47x with a straight face. This is a momentum trade with real fundamental backup. The 429% YTD isn't the problem — the multiple on a cyclical end-market is.
Verdict: Mixed signals, but the bull case survives on platform stickiness and a massive conversion tailwind. Stock down 20% in a week after the Mythos-driven rally got ahead of itself. Now we’re left with a valuation that’s still cheap vs. peers but pricing in execution that Q2 needs to deliver.
Cantor raised PT to $45 from $30, keeps Overweight. Their thesis: Tenable One adoption is building, roughly 2/3 of enterprise base unconverted — that’s a multi-year land-grab. Annual billing shift makes cRPO the cleanest demand signal, and they expect that to drive the print. They flag AI Exposure and Hexa pipeline as early proof points. Trade at 3.3x FY26 EV/Sales vs. 12.2x for peers — Cantor thinks the discount reflects too much AI risk and zero credit for platform durability.
UBS downgraded to Neutral from Buy, PT to $37 from $32. Their call: at 13x CY26 unlevered FCF, the stock is pricing in high-single-digit to low-double-digit growth. That demands either a big Q2 beat or strong H2 guidance for investors to stay comfortable. They checked partners — modestly more positive on Q2 demand but no evidence of customers increasing spend on vuln mgmt.
Truist joined the downgrade club (Buy→Hold, PT $40). JPMorgan stayed Overweight, raised to $40.
So you’ve got a split: bulls see the conversion story and cheap multiple; bears see a stock that’s already run 75% from the Mythos base and needs fundamentals to catch up.
“The current multiple reflects much of the long-term artificial intelligence risk while offering limited credit for the durability and stickiness of the platform.”
Cantor is effectively saying the market is double-discounting — once for AI disruption, once for growth deceleration that hasn’t materialized. If Tenable beats Q2 by its historical 1.9% average cRPO beat, that narrative gets harder to defend.
Bull: Conversion of the unconverted 2/3 enterprise base is a multi-year catalyst. Valuation is a joke vs. infosec peer average — 3.3x vs 12.2x. FedRAMP High clearance opens fed wallet. Product expansion (AppSec, AI Exposure) drives wallet share expansion. The stock is still cheap even after the run.
Bear: The run is already done — up 75% since Mythos, down 20% this week on downgrades, not an execution miss. UBS and Truist both think the r/r is balanced at best. Vuln management is a mature category; AI-assisted dev workflows may actually reduce vulnerability creation rates over time (negative for demand). Need to see Q2 cRPO acceleration to justify the current multiple.
Verdict: Two analysts, one stock – and the chasm is wide. JPMorgan stays overweight at $55 (28% upside from here), but RBC just slashed its target to $47 from $88 and sits Sector Perform. The stock has been shredded: DOWN 48% IN SIX MONTHS, now at $43.01 with a 52-week low of $37.08. The bull case is an AI transformation story. The bear case is macro eating everything.
RBC’s move is brutal. A PT near halved – and they’re not even bearish on the operations. They see inline results, large deal momentum ($100M+ TCV), Astreya acquisition benefits, and Project Leap driving margin expansion. The problem? IT spending headwinds and a sector-wide rerating. Enterprises are picking spots. Nine analysts have revised earnings down. RBC is being honest about valuation compression.
JPMorgan’s Tien-tsin Huang doesn’t blink. Overweight reaffirmed at $55. He’s betting on Cognizant’s AI pivot: hiring 1,500 college grads in the US, training 15,000 workers for AI deployment roles, expanded Google Cloud partnership (Gemini Enterprise), and joining OpenAI’s Daybreak Cyber Partner Program (GPT-5.5 for cybersecurity). Plus the new Neuro AI Trust platform for governance. At a 3.07% dividend yield, he sees a floor.
Bull (JPMorgan): The transformation is real. 5,000 Frontier Certified Engineers, 10,000 Frontier Business Operators – that’s a workforce reshaping. Google Cloud and OpenAI partnerships give credibility. Cybersecurity practice with 5,000+ pros. At 28% upside from the current bloodbath, r/r flips if macro stabilizes. And the yield buys patience.
Bear (RBC): Doesn’t matter how good the deals are if the macro backdrop sours. Enterprises are delaying large commitments. Mid-single-digit topline isn’t enough to re-rate the multiple. 9 downward revisions suggest earnings momentum is broken. The PT cut to $47 is just following the sector down – and it could go lower if spending stays cautious.
“RBC Capital lowered its price target based on broader IT Services sector rerating … The firm remains cautious given heightened macroeconomic uncertainty and IT spending headwinds, where enterprises have been selective with large investments.”
That’s the heavyweight narrative today. JPMorgan is the contrarian call. Watch the next print – if guidance holds, the bull case gets a pulse. If not, RBC’s rerating story wins.
Bearish signal. HSBC cut INFY to Hold from Buy, slashing PT to INR1,110 ($11.47) from INR1,340 ($14.24). The trigger? A Q1 miss and a full-year FY27 guidance trim that was sharper than expected.
The numbers tell the story. Revenue came in at $5.082B, just below the $5.1B bogey. The FY27 constant currency guidance range got clipped to 1.5%-3.0% from 1.5%-3.5%. Dig into the M&A-adjusted version and it gets uglier: -0.2% to +1.3%, midpoint ~0.8%. That's basically flattish organic growth in a year when the comp should be easier.
HSBC had anticipated a cut. But the magnitude surprised even them. The drivers are specific but structural: one Energy client contract termination (50bps drag), a Manufacturing ramp-down (100bps), and ongoing pricing deflation plus offshore shift (75-100bps). That last one is the worry — it's not just churn, it's margin erosion baked into the business model.
"The guidance downgrade suggests Infosys may underperform most of its peers in FY27."
The stock is getting destroyed. Down ~17% since June 1 against a Nifty up ~2%. Now trading at $10.67 — basically INCHING above its 52-week low of $10.30, down 64% from the $30 high. That's not a dip. That's a valuation reset.
At current levels, INFY trades in line with Wipro and at discounts of 7% to TCS, 20% to HCLT, and 30% to TechM. That's a scream for value if the narrative stabilizes. But HSBC sees "lack of near-term triggers and a likely weak outlook for the next few quarters" keeping valuations suppressed.
Two more analysts lopped PTs to $450 this week — Mizuho ($480→$450, Outperform) and Piper Sandler ($500→$450, Overweight). That makes four firms now clustered in the $450-485 range post-Q2, with Morgan Stanley the low outlier at $400 and BofA still holding at $460. The message is the same: Q2 beat on revenue ($28.2B vs $26.2B est) but missed badly on EPS ($0.33 vs $0.50 consensus) . Auto gross margins printed 16.9%, well below the 19.4% bogey. That’s the headline.
The bull case isn’t dead — it’s just kicked down the road. Piper cuts 2026/27 EPS estimates on lower Energy and Auto margins, but offsets with higher FSD contribution estimates and raised Service segment margins. Mizuho flags FSD attach rate hitting 55% with 1.5M subs (+16% QoQ), backlog at highest since 2023, and Cybercab now producing in 7 cities with 380K+ unsupervised miles. Capex stays above $25B in 2026 and grows into ’27/’28 for Terafab, Optimus, and Robotaxi.
Mizuho: "The company’s Full Self-Driving feature achieved a 55% attachment rate with 1.5 million subscriptions, up 16% quarter-over-quarter. The company’s backlog reached its highest level since 2023."
That’s the rate-of-change signal PMs should watch. Subscriptions growing quarter-over-quarter at 16% while the base expands — that’s the path to a recurring revenue moat. But until margins stabilize, this stock stays a pinball between <$300 and $350 on every macro or model-S print.
SS&C printed a clean Q2 — revenue 2% above consensus, EPS 5% above DA Davidson's model, and the reaction was... flat after-hours. That’s the tension: a company delivering record revenue, EBITDA, and EPS, accelerated organic growth, raised guidance — and the stock sits. Both Needham and DA Davidson reiterated Buy, with PTs of $90 and $96 respectively (current ~$85). The market wants proof this acceleration sticks.
"Shares are positioned to re-rate as organic growth sustains, margins expand, and share repurchases continue." > — Needham
DA Davidson said it will update its forecasts soon, but kept the $96 PT — implying ~13% upside. Both are betting on sustained execution, not a one-off.
Bull case: This is a compounding machine. Record revenue, record EBITDA, record EPS, accelerating organic growth, and a buyback that keeps the float shrinking. If they sustain 7%+ organic growth, the multiple compresses from here and the stock re-rates meaningfully. AI narrative (WorkHQ) adds optionality without being priced in.
Bear case: After-hours flat says the market expected more — maybe on guidance, maybe on margins. 2% revenue beat and 5% EPS beat are solid, not spectacular. The stock is up 20% YTD already; the easy money is made. Micro-cap M&A integration risk (Calastone) and lingering FX headwinds keep the discount intact. Re-rate won't happen until growth sustains another quarter or two.
Benchmark reiterates Buy ($525) into the July 28 print — they’re framing MSFT as an AI operating system story, not a near-term earnings beat. The stock at $383 (21% below PT) smells like a positioning entry if you buy the narrative that Azure momentum + Copilot seat expansion is real, not just capex theater. Key KPIs: Azure growth rates, AI ROI commentary, free cash flow margin — all the usual tension points.
“Microsoft is transitioning from a frontier AI partner into an AI operating system and orchestration layer for enterprise AI adoption.” — Yi Fu Lee, Benchmark
That’s the long-duration thesis. Near-term risk is if management signals slower AI monetization or margin compression from buildout. But at these levels, the r/r is tilted bull for anyone who thinks Azure re-acceleration is coming.
UBS upgrades to Buy from Neutral (new PT $90 from $80) — the call is about rate of change in advanced packaging, not just peak AI hype. The stock is down 30% from June highs, now trading at 21x 2027 P/E (current TTM multiple is 37x, but forward is compressing). The thesis: server CPU volumes are firming, base business is growing, and capacity is tightening enough to push through price increases. The Arizona fab startup costs and capex overhang are already priced in after the sell-off.
"We now view Amkor more favorably due to its leverage to the strengthening server CPU market and continued advanced packaging opportunities from the AI cycle."
Near-term catalyst: earnings print July 27 — options imply a 15% move (history shows 3 of last 8 beats implied). The TSMC/AMD packaging partnerships and the expanded Arizona campus give the narrative longer legs, but execution on the ramp is what matters for the multiple.
Oppenheimer bumps PT to $325 from $300, Outperform. The call is all about the cyclical setup ahead of Tuesday's print. They see broad-based YoY growth across every segment, channel inventory back to the 11-week bogey, and no material impact from the memory shortage. This isn't a beta call — it's a specific view on utilization and mix inflection.
"We view 63% gross margin as attainable as utilization approaches the mid-to-high 80% range."
The data center narrative is the hidden gear here. Revenue tripling from $200M in 2025 to north of $500M this year, split between industrial IoT and comms. TAM is $3-4B and growing ~10% annually — still small vs auto exposure, but the rate of change is the point. Gross margin expected at 58% (+90bps QoQ) on improved utilization and mix, with the 63% target implying real operating leverage if utilization breaks higher.
Cantor and Barclays also overweight with $400 and $340 PTs respectively. Consensus is getting crowded on the call, but the sharp acceleration in DC and the clean inventory picture give the thesis concrete hooks. Stock at $277, up 29% YTD — not cheap, but the cyclical momentum and margin expansion path keep the r/r intact into the print. PMs should watch the utilization commentary closely; that's the swing factor for 2H estimates.
SMCI is a two-step forward, one-step back story. Preliminary June quarter revenue came in at the LOW END of $11-12.5B guidance — Mizuho cuts PT to $34 (from $44), Neutral. But gross margin printed 15-17% vs guidance of 8.2-8.4%, a massive beat. Needham and Rosenblatt both raise to $46/$45 respectively, calling the recent capital raise an attractive entry point. The $60B+ backlog gives FY27 a real backbone, but execution risk (component shortages, shell construction delays) isn't going away.
"The revenue shortfall reflects potential component and memory shortage headwinds as well as shell construction delays." — Mizuho
Net: GM ramp is real (mix shift to traditional/agentic AI + direct-to-chip liquid cooling), but top-line volatility keeps the stock in penalty box territory. PMs can play it — just know the r/r is binary until those new orders convert.
DY ripping 68% in the last year – and UBS sees more runway. Data center fiber connections, not just broadband, are the new growth engine. UBS maintains Buy, $611 PT (38% upside from $444 close). Their model validates Dycom's own $20B five-year opportunity, projecting a $19B total contractor market over 2025-29 with annual spending nearly tripling from ~$2.3B to ~$6B.
The Q1 beat was a monster: EPS $4.42 vs $2.72 consensus, revenue $1.965B vs $1.67B. That's real execution, not just weather tailwinds (though Cantor noted favorable weather helped). Revenue up 30% LTM, analysts modeling 37% for FY27.
"Data center fiber connections have emerged as one of the key growth pillars for Dycom and other telecom contractors over the next several years."
The bull case is straightforward – the fiber-to-the-home cycle is still going, and now data center interconnects layer on top. Dycom's own estimate of $20B (with potential upside) now independently confirmed by UBS's bottoms-up model. Stock’s run hard, but if you believe the spend trajectory, forward multiples aren't egregious. The risk is execution at scale and labor availability, but the backlog and cadence support the narrative.
Needham’s Laura Martin stands alone this morning with a Hold — and she’s not mincing words. Her thesis: META is spreading capital across too many money-losing projects (LLAMA, Quest, Orion, Ray-Ban Glasses, Metaverse, Reality Labs) and the odds of any one hitting are low. ROIC still sits at a solid 25% LTM and gross margin is 82%, but she argues that’s exactly why the company should stop diluting returns by funding these "strategy diffusion" bets.
"We believe Meta’s strategy diffusion destroys economic value. Meta is asking for too much capital for too many projects, and intense competition lowers the odds of success in any of them."
Bernstein and Mizuho are still Outperform (AI story, ad strength, upcoming 7/29 print) — so the bull case hasn’t cracked. But for PMs watching capital allocation, Martin’s push to "shut down the losers" is a clean counterweight to the mega-cap hype. Worth noting she’s not wrong on the math: a company that can generate 82% gross margins doesn’t need to swing at every pitch.
GEV keeps ripping — 66% in the last year, trading $1,031 vs. Mizuho's fresh $949 target. They stayed Neutral, bumped the PT 4% on gas turbine capacity expansion. Stock doesn't care.
Mizuho's thesis: higher pricing from booked orders + electrification tailwinds in transmission equipment. They baked in elevated data center sales through 2034. That's a long horizon to discount. The real squeeze is the HA fleet service monopoly — only GEV makes the parts. But the "gigawatt capacity for servicing remains unclear." Weak spot.
Backlog today: 20% data center / 80% traditional (utilities, industrials). As the SRA book converts, that flips to 30/70. Not a revolutionary shift, but it’s moving in the right direction. Capacity target: 30GW by 2030.
"GE Vernova is the only manufacturer making compatible parts for this equipment, though the gigawatt capacity for servicing remains unclear."
Elsewhere in the article: Guggenheim went to $1,450 (Buy), Oppenheimer to $1,338 (Outperform). The Q2 print was mixed — $2.47 EPS missed $3.04 consensus, but revenue of $11.1B beat $10.73B. Orders surged 88% to $24.2B. Backlog hit a record $176B. The bull case is baked into the price. The bear case is simply "what's left to discount?" Mizuho isn't wrong.
Baird bumps PT to $330 (from $310) on solid FQ3 expectations — but admits the stock’s 38.88x P/E is “rich relative to past trends.” They’re leaning on $129B in trailing FCF, a coming product cycle, and early Siri AI buzz to justify the multiple. Not a raging buy — more of a “port in the storm” narrative as mega-cap peers blow billions on capex.
“Port in the storm (of software and mega-cap tech capex). We expect solid FQ3 results, driven by strong iPhone growth and steady services trends. Valuation looks rich relative to past trends, suggesting much may be priced in, but we expect the strong free cash flow, upcoming product cycle and early positive comments on Siri AI to support the stock.”
Memory pricing remains a headwind (Baird flags price hikes easing pressure). Elsewhere, Evercore holds at $365, Apple’s prepping a Mac refresh with M6 chips, and the Apple Upgrade leasing program (backed by Klarna) launches July 28. DOJ settlement chatter is still noise — watch the July 30 print. Options imply a 3.5% move.
VERDICT: PEGA is getting smoked — and the tape has more selling to digest before the value case works. Q2 missed on both revenue and EPS (print: $0.35 vs $0.43 est; rev $420.7M vs $427.4M) and the guide was soft enough to trigger two downgrades (Loop to Hold/$25, William Blair to Market Perform) and a PT chop from Rosenblatt ($47 from higher). DA Davidson held the Buy but slashed PT to $32 from $55 — a massive cut that says "I like the FCF but visibility is horrid."
The core issue: AI confusion is freezing deal cycles. Customers aren't sure where Pega fits in the new stack, so buying decisions slip. Cloud revenue grew 28% but still missed. Term license beat ($82M vs $77.8M), but that’s a short-duration tailwind, not a durable signal. Stock now trades near the 52-week low ($25.10) — a 20% drop in a week, 19% on the day.
"Demand trends deteriorated in the near term." — DA Davidson's Lucky Schreiner, maintaining Buy but clearly less constructive.
Bull vs Bear – The bull case rests on a 12% FCF yield, PEG ratio of 0.25, and a belief that FY27 FCF can surprise to the upside. The bear case says ACV and FCF missed for two consecutive quarters — that pattern doesn't fix itself without a catalyst. Right now, the narrative is "nobody knows where AI lands," and that's a toxic setup for a platform like Pega. Watch the $25 level — if it breaks, the value argument gets tested hard. If it holds, the buyback and FCF yield might attract distressed buyers. Not a PM-level position yet.
Cantor sees the cloud migration pain as a necessary evil — and the setup into 2027 is starting to look compelling. PT to $55 from $35 (stock at $44.78). 78% gross margins provide a cushion while the on-prem ARR runoff drags top-line growth. The real signal is SaaS ARR ex-conversions, which needs to print above 26% growth and a 2-3% revenue beat to trigger an inflection.
"A pure-SaaS growth and margin profile in fiscal 2027 supports a higher multiple than the market currently assigns."
Partner survey was tiny (n=5) but directional: 100% at or above plan, 40% above plan (vs 33% prior). 80% cited more favorable incentives q/q. Not a data dump, but encouraging for H2 pipeline. VRNS trades at 6.9x FY26 EV/S vs peer avg of 7.5x — the discount narrows if the SaaS transition accelerates.
UBS raised to $58, Stephens upgraded to Overweight on potential PE interest — adds to the crowded long base. The GovRAMP authorization and Atlas integrations (Claude, Cursor) are incremental tailwinds, not the core thesis.
The play: Wait for the June quarter print (likely soft headline numbers), then assess whether new SaaS logos and pipeline velocity justify a re-rating. If SaaS ARR ex-conversions hits 27%+, the stock has r/r to $55+. If not, you’re paying 6.9x for a messy transition.
Clean print, cleaner setup. Stifel to $775 (from $750), Needham to $750 (from $735) — both Buy, both reacting to the same story: Q2 beat on both top and bottom. Revenue $1.66B (+9.8% y/y) vs Street $1.58B, EPS $6.28 vs $5.79. Organic growth 9%. Book-to-bill 1.23x, 11th straight quarter above 1.0x, backlog sitting at $5.0B. They raised FY26 sales guide by $120M to ~$6.535B — that's 7% yoy growth. Also paid down $450M of debt, leverage now 1.1x. Balance sheet is a weapon.
Not much debate here: demand continues to outrun delivery, and mgmt is conservatively guiding then beating. Year-to-date +27%, P/E 31.3x — not cheap, but the compounding narrative (record orders, strong cash conversion, M&A optionality) keeps the r/r attractive. The debt paydown signals mgmt is thinking about the next deal, not just de-levering.
Maxim sees 250% upside ($1 PT vs $0.28) betting entirely on the disinformation detection boom. TAM is real — Gartner says $30B by 2028 — and the client list (State Dept, NATO, PepsiCo, WarnerMedia) gives the product some cred. But the balance sheet is a wreck: $3.1M cash, $12.6M working capital deficit, current ratio 0.23, burning fast. The $6M July raise buys air but not a long runway. This is a pure call on ARR compounding (projected 53% this year) before the cash clock runs out.
"Maxim Group initiated coverage on Cyabra with a buy rating and a price target of $1.00, citing growth opportunities in the disinformation detection market."
Verdict: FOUR looks washed out but not dead. D.A. Davidson reiterates Buy with $74 PT (60% upside). The stock got absolutely shredded — down 55% in the past year, trading at $46.74 from a $107 high. That’s a lot of pain priced in.
Support: Davidson expects Q2 (due in ~3 weeks) to meet or modestly beat, with management likely affirming or slightly tweaking guidance. The valuation argument: ~6-6.5x 2027E EBITDA of $1.39B. That's cheap for a payment processor if the story holds. Risks are real — acquisition integration and leverage (Moody’s just downgraded senior unsecured notes to B1). But the new Shift4 One handheld device rolling across Europe and the Lydian crypto partnership show they’re still trying to grow.
The setup: options activity spiked — 6,433 contracts traded recently. Not sure we can read much into that, but it suggests someone’s making a bet ahead of the print. Worth watching given the beat-down. If Q2 comes in clean, this thing could snap back hard. If it doesn’t, the 6x EBITDA floor might get tested.
Morgan Stanley threw the hammer down — initiates Overweight with a $263 PT on a stock that closed at $109.86. That's 140% upside baked into a REIT endgame framework. They value the existing energized sites at $3.7B ($11.70/watt), a discount to the ~$17/watt precedent transactions, but argue the real prize is the 2,680MW in exclusivity (including the River Bend 1GW expansion). Base case on that pipeline: $11.6B. And the recent 352MW lease at Beacon Point (same high-IG tenant expanding) just validates the model. Meanwhile, Benchmark, Needham and Rosenblatt all raised PTs to $145-195 after Nvidia exercised its option on the remaining capacity — the collective thesis: HUT is becoming a legitimate HPC landlord, not just a bitcoin miner.
"Until TeraWulf announced a $19 billion deal at Justified Data Campus, Hut 8’s $18.50 per watt in estimated equity value creation from the River Bend Campus deal represented the most attractive terms to a high-performance computing company."
Morgan Stanley's base case on the exclusivity pipeline is $11.6B -- that's the number to watch. Execution risk is real (hence the discount), but the rate of change in signed HPC leases is accelerating, and the sell-side is finally starting to build a floor under the stock. At 12x market cap, the r/r is asymmetric if they keep signing.
The legacy Domo thesis is dead. This is now a cash shell with a tax asset, not a standalone BI platform. Cantor downgraded to Neutral (from Overweight) and PT to $4.84 — which is simply the projected net cash per share post-close. The asset sale to Progress Software for $400M turns this into a stub trade: ~$246M net cash ($4.84/sh), plus >$900M in NOLs, with Founder/CEO Josh James sticking around as the vehicle's steward. The three-year global non-compete means no pivot back into BI/automation.
"The remaining company is subject to a three-year global non-compete covering competing business intelligence, data integration, workflow automation and enterprise AI products. The Board plans to use transaction proceeds to identify opportunities to monetize the NOLs."
The math is simple. At $4.07, you're buying at ~16% discount to the cash stack ($4.84) with optionality on NOL monetization (unlikely to be fully valued given complexity and timeline). The $13.5M termination fee is small relative to the asset sale, so deal risk is low — no financing condition, HSR-only. Closing by Nov 30. This is a special-situations wrapper now, not a TMT growth story. The equity's future depends entirely on capital allocation decisions by a board that will have ~$250M cash, zero debt, and a mandate to find AI/automation tuck-ins OR return capital. Hard to get excited about either from a r/r perspective given James retains control and there's a three-year non-compete limiting M&A scope.
RBC cuts PT to $129 (from $130) but keeps Outperform — that's basically rounding error on a stock at $100. The Q2 EBITDA miss on memory costs and FX is real (gross margin 12.8% shows the squeeze), but the bigger fear — OEMs in-sourcing cockpit domain controllers — is what RBC is pushing back on hard. They think the OEM-threat narrative is overdone, especially for high-volume, multi-platform builds where tier-1s still have the edge.
"Vertical integration is far more challenging for high-volume, multi-platform OEMs."
Throw in a net cash position (~$400M+) as a buffer against supply disruptions, and RBC sees 29% upside from here. Not a screaming buy, but the risk/reward looks decent if you buy the in-sourcing thesis being noise rather than music.
Dig in. KeyBanc stays Overweight, $680 PT, rolling to 2028 — sees Q2 as a “check the box” quarter where net adds clear the bar. But the tone across The Street is far from uniform: Benchmark cut its PT to $650, Rosenblatt sits Neutral at $531, while Citizens and Cantor are constructive but not blowing doors off. The common thread? Pricing/timing uncertainty is forcing forecast tweaks, yet the underlying product momentum is real.
“KeyBanc sees potential for Spotify to exit the year with faster revenue growth and normalizing operating expense growth, which could bolster sentiment.”
The r/r still favors bulls here — 0.24 PEG ratio (InvestingPro) is hard to ignore for a name with 13% rev growth expected in 2026. The risk is that margin expansion gets pushed out again (see Benchmark’s concern). But with KeyBanc forecasting 3% above Street on rev and op profit for 2028, conviction on the multi-year story is holding. Net-net: positioning appears decent, but don’t chase into a quiet quarter — buy the dip if currency or tier timing spooks PMs.
Cantor Fitzgerald is sticking with Neutral and a $150 PT (stock at $125.60, down 29% in six months, sitting 44% below the $224.20 high). The call is about timing, not conviction. They see Q2 as the trough of a go-to-market disruption — the July 30 print matters less for the headline number and more for whether the disruption is behind them.
"The bar for the stock to work depends less on the headline earnings print than on evidence the disruption is behind the company."
Long-term case still hangs on Infinity adoption, CTEM ramp, and M&A — but near-term sentiment is horrid. 33 analysts have cut estimates into this print. The P/E is 13x, PEG 0.44 — cheap on a multiple, but value traps are real when the narrative is broken. Meanwhile, options call volume surged to highest since 2021 (someone is betting on a snapback) while Raymond James downgraded to Market Perform and Guggenheim upgraded to Buy with a $188 target (43% upside). The range of views says this is a show-me stock: either the disruption ends here or it deepens. No edge guessing that ahead of the print.
BUY THE DISRUPTION THESIS. Freedom Capital initiates with a Buy and $26 PT (20% upside from $20.76), leaning hard on the cost advantage story. Chime serves the 196M Americans earning <$100k at ~$135/head vs. $450-740 for incumbents. That unit economics gap is the moat. Revenue $2.3B, 29% growth, 88% gross margin – and now GAAP-profitable in Q1 (EPS $0.13 vs consensus -$0.08). The 5x EV/2026 transaction profit multiple looks cheap if growth sustains.
"The company’s cost to serve customers at approximately $135 annually, compared to $450 to $740 for incumbent banks serving the same demographic."
BMO’s $30→$28 tweak and Goldman’s top-pick call reinforce the narrative, not the other way. The stock is pricing in execution risk on Prime monetization and the Q2 print – but the base case works. Rate of change is positive.
Verdict: Cheap stock, aggressive buyback, but revenue quality is the question. D.A. Davidson keeps Buy / $30 target (48% upside) ahead of August FQ3 print. The bull case rests entirely on the capital return story: $116M in buybacks YTD, taking out ~15% of the float. Management is putting their money where their mouth is.
But look under the hood — the street is not uniform. Multiple firms have trimmed targets to $27-30 from a prior $30-39 cluster. The culprit: professional services revenue softness in H1, which offset a 12% ARR acceleration (SaaS +37%). The market is pricing in execution risk, not a broken model.
"Management has been aggressively buying back shares — more than 5 million shares, or ~15% of shares outstanding year-to-date." — D.A. Davidson
Net-net: This is a r/r call on whether the buyback can close the gap vs. the revenue mix shift. If FQ3 shows pro services stabilizing, the $30 target becomes floor, not ceiling. If not, the buyback is just masking a grind.
DA Davidson holding firm at Buy/$82 ahead of the Q2 print (due July 29). That's 54% upside from here. They're on the Best-of-Breed list. Thesis is straightforward: QTWO meets or slightly beats on Q2, affirms or modestly fine-tunes 2026 guide, and — more importantly — gives preliminary 2027 guidance. The stock already ripped on Q1 beat (subscription rev +17% y/y, margins expanding post-cloud migration). Low P/E, PEG ratio of 0.1 gets flagged. For a $5B market cap fintech grinding through a massive transition, that's a cheap setup.
But the price target dispersion tells a different story. JPMorgan cut to $60 (from $80) last month, Morgan Stanley goes $63. Both still Overweight/Equalweight but clearly marking down valuation after the cloud migration "completion" narrative got priced in. The AI angle (Q2 Assistant launch) is real but JPM says concerns about AI-defensibility are "overstated" — which implies the market is discounting them. DA Davidson is the outlier at $82.
"D.A. Davidson added Q2 Holdings to its Best-of-Breed list, reiterating a Buy rating with a price target of $82."
The dig. Setup is fine — beat-and-raise quarter, margin story intact, cloud migration behind them. The question is whether 2027 guidance is enough to re-rate the stock back toward $80, or if the AI/competitive narrative keeps the lid on. For now, the r/r is skewed long if you believe the P/E compression is a buy signal. The PEG at 0.1 is screaming cheap. The market isn't listening. Yet.
Verdict: M&A bid is the only thing holding this name above $50. Standalone turnaround is still broken.
Truist upgraded to Hold (from Sell) with a $57 target, citing a "real" bid from Stripe/Advent. The analyst sees deal synergies as a potential catalyst but warns that if it falls apart, negative revisions are likely.
"The bid from privately held Stripe is real and a combination of the two firms could create potential synergies." — Truist's Matthew Coad
Rest of the Street is lukewarm. Cantor at $54, Canaccord at $55, Clear Street at $61, Macquarie at $50. Consensus is effectively a Hold with deal optionality baked in. Earnings on July 29 could break the stalemate — options imply a 5.2% move. For PMs: this is a crowded short squeeze candidate if deal talks leak, but the fundamental path is still a slog.
Verdict: MS throws cold water on the yield story, but the market is pricing in the expansion, not the current math. Initiation at Equalweight, $36.50 PT — about 17% upside from here, but that’s a low bar for a stock that’s up 175% in a year. The core critique: unlevered yields on capex below 15%, NAV/watt ($3.93) trailing peers RIOT and HUT. MS values the book on six leases at Polaris and Delta Forge — $36B in contracted revenue over 15 years — but explicitly excludes the “up to a GW” expansion potential. That’s the gap between the analyst and the narrative.
Management’s three priorities sound sensible: lock in long-term MW at existing sites, prevent tenant sublease transfers down, cap SLA liabilities. But the cash burn is real — $0.46/sh LTM loss, 66% revenue growth to $319M, yet cash is flying out the door. The Chronoscale spin (96% stake owned) is a wild card in NAV, but not a near-term catalyst.
Strongest line from the note:
“Morgan Stanley expects unlevered yields on capex below 15%, which reduces equity value creation relative to deals by other Powered Shell Providers.”
That’s the steelman bear case. Meanwhile, Compass Point and Northland are out at $70 and $82 respectively — they’re buying the hyperscaler lease momentum (three sites, 810MW in 60 days with a new customer). MS is saying the r/r is meh at current levels unless you believe the expansion pipe is real and the yield math compresses. I’d side with the bulls on rate of change, but the cash burn is a bogey that keeps this in “show me” territory.
DA Davidson bumps PRGS to $45 (from $40) on the Domo acquisition – calls it a margin improvement story. The $355M buyout for substantially all of Domo’s assets at ~1.1x DA’s CY26 rev is cheap if they can wring out S&M costs. PRGS already runs 85.6% gross margins, so the operating leverage case is clear. New PT sits at the low end of the $45–$83 Wall Street range – speaks to execution risk, but the Buy rating is intact.
The firm views the acquisition favorably primarily due to the significant margin improvement that Progress Software can deliver from Domo, particularly around sales and marketing.
Guidance for FQ3 (reporting Sept 30) was reaffirmed. Not a home run, but a solid risk/reward for a name trading below fair value per the article’s own analysis. Keep on radar for value-oriented PMs.
Verdict: TEM’s acquisition of Personalis is a bet on owning the tumor-informed MRD franchise. Stitch together the NeXT Personal sensitive ctDNA assay with Tempus’s multimodal data + AI stack, and you get a potential one-stop shop for liquid biopsy. H.C. Wainwright reiterates Buy, $64 PT (~39% upside from $46). Canaccord goes even further at $80. But the deal is a 100% stock transaction at ~$1.5B EV – dilution concerns linger, and Jefferies stays Underperform, $35.
“NeXT Personal has industry-leading sensitivity for detecting small traces of circulating tumor DNA, enabling tracking of cancer treatment response, detection of residual cancer and early detection of recurrence.”
The street is split: Guggenheim raised to $65 (Buy), Freedom Capital initiated at $59 (Hold). The real question is whether TEM can digest a $1.5B all-stock bolt-on without cratering its own equity. Rate of change is positive on MRD narrative, but the stock has already dropped 12% in the past week – market pricing in integration risk. Watch for close timeline (late ’26 to early ’27) and any cash-option mechanics that signal management’s confidence.
BE — Expert call frames a multi-year availability window. Turbine OEMs are deliberately NOT expanding capacity — they fear stranded factories when projects fail FID. If that discipline holds, Bloom's window is YEARS, not quarters. The LCOE gap is small enough to stick (gas turbine 4.5-7c/kWh, Bloom just over 7c). Execution risk is the real bear case. Demand is not.
AVGO — THE $811B GOOGLE PO NUMBER IS STAGGERING. Extended through 2031 with minimum volumes RISING EVERY YEAR. This de-risks the entire custom silicon pipeline. Also ramping Meta, OpenAI, Anthropic as multi-GW/year customers. Hock Tan secured the bag.
NVDA — Jensen's first X post reads defensive — lobbying for open weights to protect CUDA moat against AMD/GOOG/AMZN merchant silicon. 2028 Feynman architecture with dual-layer optical design confirms roadmap. Hardware floor backstop turns neocloud clusters into bankable projects. High quality but implied AI revenue runrate already in low single-digit trillions. Hard for revisions to go up from here.
MU — LOSING ~$67.5B IN MARKET CAP TODAY. Triggered by bearish Korean analyst note and CXMT pricing power. CXMT pricing HIGHER than Samsung for 64GB DDR5. Near-term commodity DRAM oversupply fears are real. HBM demand strong but consumer DRAM facing Chinese competition.
QCOM — Supply chain average price increase modeled at 22%. Qualcomm's increase is UNDER THAT AVERAGE. Suggests less pricing power in merchant silicon as segmentation kicks in between frontier and open models. Merchant silicon future safe but margins compressed.
ASML — Raised FY26 guidance for the SECOND time in three months. EUV output growing 30% for next 2 years. Equipment lead times DOUBLING, locking in multi-year demand. Foundry capex raises (Intel, TSMC) support the tool thesis.
AMAT — Lead times for top 5 semicap manufacturers have DOUBLED to 12 months. Applied Materials is in that top 5 (70% of global market). Massive backlog and pricing power. Samsung and SK hynix ordering earlier to secure supply.
KLAC — Same dynamic for inspection/process control equipment. Yield management for advanced nodes is mission critical. Intel beat + capex raise is a direct positive read-through.
LRCX — Etch and deposition lead times also doubled. Memory makers directing capex to HBM and DDR5, driving equipment demand. Broad-based demand profile.
UBER — Waymo exploring exit from the robotaxi partnership. Atlanta and Austin exclusivity expires in 2028. If Waymo leaves, Uber loses its best supply partner. Market reaction muted but the risk is structural. Uber's autonomous strategy may be compromised.
ORCL — CDS AT RECORD WIDES. Bond market is punishing the balance sheet. Signed $7B Pentagon contract showing government demand but credit market is leading equity on AI capex ROI concerns. Weak balance sheet in a capital-intensive business.
BX — Blackstone-led group invests $5.34B for 49% of 2.59GW behind-the-meter power projects with Williams. Template for financing BTM power with IG hyperscaler offtake. Capex $3.5M/MW targeting 6.35% IRR. Private capital is flowing.
SLB — FQ2 beat (EPS $0.55 vs $0.53, revenue $8.97B vs $8.72B). Energy benefiting from oil above $100/bbl on Iran tensions. Geopolitical bid is real.
VZ — FQ2 miss (EPS $1.30 vs $1.31, revenue $34.25B vs $35.35B). Telecom facing capex and competition headwinds. Not an AI winner. Skip.
AXP — FQ2 beat (EPS $4.53 vs $4.50) but revenue miss ($19.64B vs $19.79B). Raised FY revenue guidance to 10%. Consumer spending resilient despite macro noise. High quality name but no AI catalyst.
RTX — New all-time highs. Defense rotation is real as geopolitical tensions escalate. US tech trade policy uncertainty supports the defense bid.
Hearing Bloom Energy expert call (Tegus, former Plug Power VP) was materially more bullish than consensus. His take: turbine OEM discipline creates a multi-year availability window. "Hyperscalers chose turbines, discovered they could not get them before 2030, and Bloom was the alternative that checked enough boxes." The LCOE gap is small enough to be durable even post-normalization — 4.5-7c for gas turbines vs just over 7c for Bloom. His five-year market share projection: 15-18% (from single digits today). Upside case: 40-50%. That's a 4-5x revenue multiple expansion if execution holds.
Word is Intel's 7th consecutive beat with capex raised from $18B to >$20B for 2026 — and 2027 "significantly above" — is being framed as a structural foundry pivot. External revenue accelerating +68% q/q. Street models still too low on the revenue trajectory. The foundry capex raise is also a direct positive read-through for semicap equipment names (AMAT, KLAC, LRCX).
Channel checks suggest Korean presidential chief of staff signaled "very large-scale" contracts with US tech companies during Silicon Valley visit. Read-through for HBM and memory pricing. Samsung and SK Hynix could be securing long-term, escalating commitments similar to AVGO's Google deal. MU is getting crushed on CXMT fears but the Korean government angle is the counter-narrative.
Hearing Anthropic is aggressively expanding into adjacent services — multiple companies described as being "boned by Anthropic" in a list circulating on Twitter. The specific names weren't detailed but the pattern suggests they're moving up the stack into application-layer services, competing with their own ecosystem partners.
Word is NVIDIA's open weights lobbying letter has ecosystem partners (Microsoft, Palantir, ServiceNow, Box) but notably NOT Amazon or Google. Battle lines are drawn: NVIDIA/Microsoft/Meta vs Anthropic/OpenAI/Amazon/Google. Jensen's first X post is being read as a defensive play for CUDA ecosystem against encroaching merchant silicon.
Channel checks suggest Hyperscaler CDS hitting record wides — led by ORCL and SPCX — is the bond market's way of voting on AI capex ROI. The trade is: credit market is right, equity market is wrong. BUT the Convequity barometer shows ROIC/WACC still at 3.05x in Q1'26, up from 2.96x. The bull case: bond market is early, not wrong.
Hearing a recurring theme from multiple AI thought leaders: RSI (recursive self-improvement) could make frontier AI capabilities go "exponential" in the next 6-9 months. OpenAI and Anthropic are expected to extend their lead dramatically. If true, the compute demand curve steepens again just as the market is questioning capex ROI.
Word is a thought experiment gaining traction: what if automated AI research shifts the bottleneck from training clusters to INFERENCE capacity before frontier training runs ever scale to 5-10-20 GW? The scarce resource becomes inference capacity to serve the RSI-type model. If that's right, the bull case for inference compute (NVDA, AVGO networking) gets structurally stronger.
Channel checks on distillation — multiple voices now arguing that a meaningful portion of frontier labs' ARR is driven by distillation from competing models. Satya's "reverse information paradox" is being cited. If distillation is structurally impossible to prevent, the pricing power of frontier models erodes faster than the IPO narrative suggests. NVIDIA's position on open weights is directly tied to this — they benefit from models being open because it drives inference compute demand.
Hearing enterprise AI adoption is gated by ALLOCATION, not budget. "Uber burned its annual Claude Code + Codex budget in four months." The macro productivity gains require management to greenlight radically different staffing — and they haven't done it yet. Expect this to take 10 years, not 2.